TARGET AUDIENCE
This activity is intended for cardiologists, primary care physicians, diabetologists/endocrinologists, emergency medicine physicians, nurse, nurse practitioners, and physician assistants involved in the care of patients with or at risk for cardiovascular disease or cardiometabolic disorders.
GOAL STATEMENT
The goal of this activity is for learners to be better able to optimize patient outcomes with improved ability to convey the debilitating impact of congestion in heart failure (HF), recognize the benefits and limitations of standard of care (SOC) treatment for fluid overload in patients with worsening HF, evaluate emerging therapeutic innovations to address unmet medical needs in treating congestion in worsening HF, and identify the role of the interprofessional team in diuresis management and integration of solutions into practice for appropriate patients.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST][ITEM]Clinical consequences of congestion in worsening HF [ITEM]Unmet medical needs in the treatment of worsening HF due to congestion [ITEM]Novel subcutaneous therapeutic modalities for the management of worsening HF[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM] Integrate new approaches to HF management into treatment plans for appropriate patients [/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 0.75 [bold][italic]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs.
Supported by an independent educational grant from [bold]scPharmaceuticals Inc.[/bold]